Jiangsu Hengrui Pharmaceuticals Co.,Ltd (SHA:600276)
China flag China · Delayed Price · Currency is CNY
50.58
-1.01 (-1.96%)
May 20, 2026, 11:29 AM CST

SHA:600276 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
40,52740,95524,81620,74615,11113,631
Trading Asset Securities
108.92113.84273.3499.052,7605,090
Cash & Short-Term Investments
40,63641,06925,08920,84517,87118,721
Cash Growth
67.95%63.69%20.36%16.64%-4.54%13.93%
Accounts Receivable
6,4925,9096,1596,1358,3416,884
Other Receivables
15.6528.1766.41438.25562.18658
Receivables
6,5075,9386,2266,5738,9047,542
Inventory
2,8862,8782,4172,3142,4512,403
Prepaid Expenses
-166.79239.54226.07507.2431.57
Other Current Assets
2,0151,4381,3431,3291,2011,090
Total Current Assets
52,04451,49035,31531,28730,93430,188
Property, Plant & Equipment
8,1287,9086,9286,6296,6766,276
Long-Term Investments
2,1332,0301,7321,4511,5081,001
Other Intangible Assets
2,2591,9561,192883.77519.9442.45
Long-Term Deferred Tax Assets
772.03780.96377.17320.56238.9141.36
Long-Term Deferred Charges
5,3715,0904,1122,8292,052569.38
Other Long-Term Assets
586.84611.69479.11383.3442.55648.99
Total Assets
71,29469,86750,13643,78542,37139,266
Accounts Payable
2,3351,9951,5171,3341,4931,920
Accrued Expenses
1.631,405941.05578.8597.57165.66
Short-Term Debt
----1,261-
Current Portion of Leases
30.3730.9341.13---
Current Income Taxes Payable
769.97633.05242.9459.284.0321.77
Current Unearned Revenue
1,4541,913159.79198.09187.08219.55
Other Current Liabilities
1,046392.96731.36383.42596.131,074
Total Current Liabilities
5,6376,3693,6342,5543,6393,402
Long-Term Leases
37.143.3169.0475.1898.86151.59
Long-Term Unearned Revenue
1,3011,541225.6538.95119.44116.52
Long-Term Deferred Tax Liabilities
172.15116.96117.1183.64100.4524.77
Total Liabilities
7,1478,0704,0452,7513,9583,694
Common Stock
6,6376,6376,3796,3796,3796,396
Additional Paid-In Capital
12,88312,9353,1883,0583,0203,356
Retained Earnings
45,88443,60137,16432,10228,81925,928
Treasury Stock
-1,793-1,929-1,229-1,092-398.03-664.94
Comprehensive Income & Other
15.727.9616.9719.323.23-12.16
Total Common Equity
63,62661,27245,52040,46637,82435,003
Minority Interest
520.82524.75570.39567.29589.35568.85
Shareholders' Equity
64,14761,79746,09041,03338,41335,572
Total Liabilities & Equity
71,29469,86750,13643,78542,37139,266
Total Debt
67.4774.23110.1675.181,360151.59
Net Cash (Debt)
40,56840,99524,97920,77016,51118,570
Net Cash Growth
68.42%64.12%20.27%25.79%-11.08%13.00%
Net Cash Per Share
6.106.273.943.282.582.91
Filing Date Shares Outstanding
6,7136,5346,3626,3616,3676,382
Total Common Shares Outstanding
6,7136,5346,3626,3616,3676,382
Working Capital
46,40745,12131,68128,73427,29526,786
Book Value Per Share
9.489.387.166.365.945.48
Tangible Book Value
61,36759,31644,32839,58237,30434,561
Tangible Book Value Per Share
9.149.086.976.225.865.42
Buildings
-4,8923,9753,8543,5412,700
Machinery
-6,5236,1045,9695,6845,120
Construction In Progress
-2,0061,6881,1011,1931,659
Source: S&P Global Market Intelligence. Standard template. Financial Sources.